Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

19.25

-2.30 (-10.67%)

Nov 4, 2026, 11:20 AM EST - Market open

Bright Minds Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	307.83	82.91	5.72	6.75	11.63	19.76
Cash & Short-Term Investments	307.83	82.91	5.72	6.75	11.63	19.76
Cash Growth	499.03%	1349.43%	-15.23%	-41.97%	-41.15%	2370.22%
Other Receivables	1.1	0.41	0.05	0.04	0.16	0.11
Receivables	1.1	0.41	0.05	0.04	0.16	0.11
Prepaid Expenses	1.35	0.99	0.22	0.03	0.16	0.17
Total Current Assets	310.28	84.31	5.99	6.81	11.95	20.04
Property, Plant & Equipment	0.05	0.11	0.12	0.07	0.14	-
Other Intangible Assets	-	-	-	-	-	0
Total Assets	310.34	84.42	6.1	6.88	12.09	20.04

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Accounts Payable	2.36	1.71	0.41	0.18	1.25	0.6
Accrued Expenses	0.11	0.54	0.04	0.03	0.16	0.04
Current Portion of Leases	0.07	0.08	0.08	0.07	0.07	-
Total Current Liabilities	2.54	2.34	0.53	0.28	1.47	0.64
Long-Term Leases	-	0.04	0.04	-	0.07	-
Total Liabilities	2.54	2.38	0.57	0.28	1.54	0.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Common Stock	365.98	123.25	35.42	33.91	32.24	27.08
Retained Earnings	-67	-46.58	-34.35	-31.55	-24.17	-9.21
Comprehensive Income & Other	8.82	5.37	4.46	4.23	2.48	1.53
Shareholders' Equity	307.79	82.04	5.54	6.6	10.54	19.4
Total Liabilities & Equity	310.34	84.42	6.1	6.88	12.09	20.04

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Total Debt	0.07	0.13	0.12	0.07	0.14	-
Net Cash (Debt)	307.76	82.78	5.6	6.67	11.49	19.76
Net Cash Growth	500.55%	1377.97%	-16.08%	-41.90%	-41.86%	2370.22%
Net Cash Per Share	35.79	12.04	1.30	1.79	4.65	11.01
Filing Date Shares Outstanding	9.86	7.79	6.99	4.46	3.74	2.37
Total Common Shares Outstanding	9.86	7.64	4.52	3.77	3.52	2.37
Working Capital	307.74	81.97	5.46	6.53	10.48	19.4
Book Value Per Share	31.20	10.74	1.22	1.75	3.00	8.20
Tangible Book Value	307.79	82.04	5.54	6.6	10.54	19.4
Tangible Book Value Per Share	31.20	10.74	1.22	1.75	3.00	8.20

SEC Filings: 10-K · 10-Q